How Biden's vaccination plan for young kids differs from the plan for adults
The White House on Wednesday unveiled its plan to distribute the Pfizer and BioNTech COVID-19 vaccine to children ages 5 to 11 pending the shot's authorization by U.S. drug regulators, reports CNBC. But don't expect the campaign to look and feel exactly the same as it did for adults, or even teenagers ages 12 to 15.
For one thing, the "5-to-11 age group, with 28 million children, is far larger than the 12-to-15 group, with 17 million," who are already eligible for the vaccine, writes The New York Times. And unlike that for U.S. adults, the plan for the younger group also features fewer mass vaccination sites, considering children often cry and tend to be "more sensitive patients."
"We don't want lines of kids," said Sonya Bernstein, a senior policy adviser for the White House COVID-19 response team. Instead, "pediatrician's offices, children's hospitals and pharmacies with in-store clinics will be the preferred options," explains the Times. The administration is aiming for a "kid-friendly experience that makes sure that we're getting shots in arms with trusted providers in ways that makes parents feel comfortable," per Bernstein.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The shots themselves will also look different. Needles and the vials that hold the vaccine will be child-sized, smaller and more easily stored. Dosage is also expected to shrink to 10 micrograms from the 30-microgram dose used for ages 12 and up, per the Times.
Finally, officials plan to lean "heavily on local health experts, who they believe are more trusted in their communities and can help reach high-risk children," writes the Times. "Children's hospitals and health systems will be a critical part of our efforts," the administration wrote in its memo.
Said COVID-19 Response Coordinator Jeff Zients: "Should the FDA and CDC authorize the vaccine, we will be ready to get shots in arms."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published